NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...

LAWRENCE, Mass., Aug. 28, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, today announced that the U.S. Food and Drug ...

LAWRENCE, Mass., Aug. 4, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

Missing dialysis treatments can be a matter of life and death for patients with end-stage renal disease (ESRD). However, the portability of the System One allows home patients to take their machines ...

LAWRENCE, Mass. (AP) -- Medical device maker NxStage Medical Inc. said Tuesday its first-quarter loss narrowed as revenue climbed on growing adoption of its NxStage System One home kidney dialysis ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc. is celebrating its 10th year anniversary this summer of the Food and Drug Administration's ...

NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The system consists of new features and capabilities, including a new touchscreen user ...